Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal…
